Acceptability, attitudes and knowledge towards Transcranial Magnetic Stimulation (TMS) among psychiatrists in France.


Journal

L'Encephale
ISSN: 0013-7006
Titre abrégé: Encephale
Pays: France
ID NLM: 7505643

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 07 02 2019
revised: 25 06 2019
accepted: 18 07 2019
pubmed: 17 9 2019
medline: 2 2 2021
entrez: 17 9 2019
Statut: ppublish

Résumé

Non-invasive brain stimulation techniques are becoming a part of psychiatrists' therapeutic arsenal. Proof of TMS effectiveness and its indications are becoming clearer. While international recommendations exist, and many countries have already recognized the use of these techniques, the French situation is peculiar since no recommendation has been published by the High Authority of Health. Consequently, those techniques are not reimbursed by the healthcare service, few practitioners are trained, some are criticized for using it, and practices remain very heterogeneous. It is therefore important to investigate what slows down the development of these techniques. The objective of this study was to determine the acceptability of TMS by psychiatrists and to analyze the factors influencing it. A sample of psychiatrists was recruited in order to complete an online quantitative acceptability study using a four variable domain model (utility, intention of use, facility, risk) allowing an acceptability score calculation. Four hundreds and seventy-six observations were included in the analysis. Regarding the main objective, the overall TMS acceptability score was high for 47.2% of psychiatrists, average for 40.6% and low for 12.1% of them. The main factors influencing it were theoretical orientation (psychoanalytic vs neurobiological) and training level (only one in three psychiatrists acknowledge having been trained in this technique). The majority of practitioners consider TMS to be a credible alternative to current therapies, especially for depressive disorders. Yet psychiatrists are uninformed and poorly trained in these techniques and report very clearly a desire for more training and information. Our study highlights a significant lack of training that negatively impacts the accessibility of these techniques.

Sections du résumé

BACKGROUND BACKGROUND
Non-invasive brain stimulation techniques are becoming a part of psychiatrists' therapeutic arsenal. Proof of TMS effectiveness and its indications are becoming clearer. While international recommendations exist, and many countries have already recognized the use of these techniques, the French situation is peculiar since no recommendation has been published by the High Authority of Health. Consequently, those techniques are not reimbursed by the healthcare service, few practitioners are trained, some are criticized for using it, and practices remain very heterogeneous. It is therefore important to investigate what slows down the development of these techniques. The objective of this study was to determine the acceptability of TMS by psychiatrists and to analyze the factors influencing it.
METHOD METHODS
A sample of psychiatrists was recruited in order to complete an online quantitative acceptability study using a four variable domain model (utility, intention of use, facility, risk) allowing an acceptability score calculation.
RESULT RESULTS
Four hundreds and seventy-six observations were included in the analysis. Regarding the main objective, the overall TMS acceptability score was high for 47.2% of psychiatrists, average for 40.6% and low for 12.1% of them. The main factors influencing it were theoretical orientation (psychoanalytic vs neurobiological) and training level (only one in three psychiatrists acknowledge having been trained in this technique).
DISCUSSION CONCLUSIONS
The majority of practitioners consider TMS to be a credible alternative to current therapies, especially for depressive disorders. Yet psychiatrists are uninformed and poorly trained in these techniques and report very clearly a desire for more training and information. Our study highlights a significant lack of training that negatively impacts the accessibility of these techniques.

Identifiants

pubmed: 31522836
pii: S0013-7006(19)30237-4
doi: 10.1016/j.encep.2019.07.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

88-95

Informations de copyright

Copyright © 2019 L'Encéphale, Paris. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

A Bourla (A)

Department of Adult Psychiatry and Medical Psychology, Saint-Antoine Hospital, Sorbonne Université, AP-HP, 75012 Paris, France; Jeanne d'Arc Hospital, INICEA Group, 94160 Saint-Mandé, France. Electronic address: alexis.bourla@aphp.fr.

E Chaneac (E)

Department of Adult Psychiatry and Medical Psychology, Saint-Antoine Hospital, Sorbonne Université, AP-HP, 75012 Paris, France.

E Poulet (E)

CNRS, UMR5292, PSY-R2 Team, Department of Emergency Psychiatry, Lyon Neuroscience Research Center, hospices civils de Lyon, Edouard-Herriot Hospital, University Lyon, 69002 Lyon, France.

E Haffen (E)

Inserm, EA 481 Neurosciences, Department of Clinical Psychiatry, FondaMental Foundation, Créteil, and the French Association of Biological Psychiatry (AFPBN), Clinical Investigation Center 1431, University of Bourgogne Franche-Comté, University Hospital of Besançon, 25030 Besançon, France.

L Ogorzelec (L)

Sociology and Anthropology Laboratory (LaSA - EA 3189), University of Burgundy Franche-Comté, 25030 Besançon, France.

C Guinchard (C)

Sociology and Anthropology Laboratory (LaSA - EA 3189), University of Burgundy Franche-Comté, 25030 Besançon, France.

F Ferreri (F)

Department of Adult Psychiatry and Medical Psychology, Saint-Antoine Hospital, Sorbonne Université, AP-HP, 75012 Paris, France.

S Mouchabac (S)

Department of Adult Psychiatry and Medical Psychology, Saint-Antoine Hospital, Sorbonne Université, AP-HP, 75012 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH